Eczema Patients Experience High Recurrence and Job Challenges Survey: 40% Find Treatments Ineffective; Over 10% Forced to Resign HKU Research Offers Hope for Drug Resistance Issues ***Press Conference***
[Hong Kong, August 17, 2025] In the wake of the COVID-19 pandemic, as the economy recovers, businesses have heightened their expectations regarding employee health and performance. This has led to increased pressure and challenges for chronic illness patients in the workplace. Eczema (atopic dermatitis) is a common chronic condition in Hong Kong, affecting 1 in 5 individuals at various times.
